Abnormal Expression of BTLA and CTLA-4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients

Figure 4

(a) CTLA-4 mRNA expression levels in CLL and controls in a subpopulation of CD3-positive cells; (b) BTLA mRNA expression levels in CLL and controls in a subpopulation of CD3-positive cells.